Orca Bio
California, US · Founded 2015 · Delaware corporation · 6 known investors
Orca Bio develops allogeneic T-cell immunotherapies for high-risk blood cancers including acute myeloid leukemia, acute lymphocytic leukemia, and myelodysplastic syndrome. The company is advancing precision cell therapy treatments for patients with blood cancers and autoimmune diseases.
Founders & leadership
J

JeroenCo-founder and President
ID
Ivan DimovExecutive Officer, Director
NF
Nathaniel FernhoffExecutive Officer, Director
AK
Alex KolicichDirector
JM
Jonathan MacQuittyDirector
Investors · 6
Competitors · 6
by search overlapZiprecruiter75 shared keywords
Cowles_Investments_StemCentrx59 shared keywordsFierce Biotech is a news publication covering the biotechnology, pharmaceutical, and medtech industries, reporting on clinical trials, deals, venture capital, drug development, and research. It serves industry professionals through articles, special reports, events, webinars, and podcasts.
PatSnap59 shared keywordsPatsnap builds an AI-powered platform for R&D, IP, and innovation intelligence, offering tools for patent search, novelty and FTO analysis, patent drafting, and materials and pharma research. It serves R&D leaders, IP professionals, engineers, and scientists across industries including materials, manufacturing, life sciences, pharmaceuticals, and consumer goods.
Concord Communications48 shared keywords
Built In48 shared keywords
Mapquest48 shared keywordsProvider of geographical information systems and services; acquired by America Online.
Companies competing with Orca Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$192MraisedJul 2020 · 11 investors · Other Health CareRule 506(b)
▶$192MraisedJul 2020 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alex KolicichDirector
- Ivan DimovExecutive Officer, Director
- Jonathan MacQuittyDirector
- Nathaniel FernhoffExecutive Officer, Director
- Offering amount
- $192M
- Amount sold
- $192M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.